We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




H pylori Adherence Linked to Blood Group Antigens

By Biotechdaily staff writers
Posted on 04 Aug 2004
Researchers developing a vaccine for the bacterium Helicobacter pylori, the primary cause of ulcers and a contributor to stomach cancers, have found that the organism has evolved a mechanism to enhance attachment to stomach tissues that depends on preferential binding to the most common blood group antigens in the host population.

Investigators at Washington University School of Medicine (St. More...
Louis, MO, USA) were part of a multinational team seeking to develop a vaccine to prevent H pylori infection. In the current study, published in the July 23, 2004, issue of Science, they focused on differences in the attachment properties of North American strains of H pylori as compared to strains isolated from Amerindian groups in Latin America.


They found that more than 95% of strains that bind fucosylated blood group antigen bound A, B, and O antigens (generalists), whereas 60% of adherent South American Amerindian strains bound blood group O antigens (specialists). This specialization coincided with the unique predominance of blood group O in these Amerindians. Strains differed about 1500-fold in binding affinities, and diversifying selection was evident in babA sequences. BabA is one of several adhesions that modulate H pylori adherence to the stomach wall. BabA binds to the Lewis b antigen receptor.

"Most human populations have a mixture of people with blood types A, B, and O. When the bacteria spread from one person to another, they can not predict the next host's blood type, so they maintain a form of babA flexible enough to bind to all the different Lewis b receptors,” explained Dr. Douglas E. Berg, professor of genetics and of medicine at Washington University. "In Amerindian populations in Latin America, though, almost everyone has blood type O. If we can improve our understanding of how H pylori adheres to the stomach lining, we may be able to develop better ways to prevent or decrease infections. H pylori is a very clever pathogen, but its need to stick to the stomach lining may be its Achilles' heel.”




Related Links:
Washington University

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.